Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-142 |
Sentence |
denotes |
An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. |
T1 |
0-142 |
Sentence |
denotes |
An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. |
T1 |
0-142 |
Sentence |
denotes |
An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. |
TextSentencer_T2 |
143-385 |
Sentence |
denotes |
Bifidobacteria are health-promoting enteric commensals that are assumed to proliferate predominantly in the intestines of breast-fed infants by assimilating human milk oligosaccharides (HMOs) that are frequently fucosylated and/or sialylated. |
T2 |
143-385 |
Sentence |
denotes |
Bifidobacteria are health-promoting enteric commensals that are assumed to proliferate predominantly in the intestines of breast-fed infants by assimilating human milk oligosaccharides (HMOs) that are frequently fucosylated and/or sialylated. |
T2 |
143-385 |
Sentence |
denotes |
Bifidobacteria are health-promoting enteric commensals that are assumed to proliferate predominantly in the intestines of breast-fed infants by assimilating human milk oligosaccharides (HMOs) that are frequently fucosylated and/or sialylated. |
TextSentencer_T3 |
386-563 |
Sentence |
denotes |
We previously identified two different α-l-fucosidases in Bifidobacterium bifidum and showed that the strain furnishes an extracellular degradation pathway for fucosylated HMOs. |
T3 |
386-563 |
Sentence |
denotes |
We previously identified two different α-l-fucosidases in Bifidobacterium bifidum and showed that the strain furnishes an extracellular degradation pathway for fucosylated HMOs. |
T3 |
386-563 |
Sentence |
denotes |
We previously identified two different α-l-fucosidases in Bifidobacterium bifidum and showed that the strain furnishes an extracellular degradation pathway for fucosylated HMOs. |
TextSentencer_T4 |
564-649 |
Sentence |
denotes |
However, the catabolism of sialylated HMOs by bifidobacteria has remained unresolved. |
T4 |
564-649 |
Sentence |
denotes |
However, the catabolism of sialylated HMOs by bifidobacteria has remained unresolved. |
T4 |
564-649 |
Sentence |
denotes |
However, the catabolism of sialylated HMOs by bifidobacteria has remained unresolved. |
TextSentencer_T5 |
650-747 |
Sentence |
denotes |
Here we describe the identification and characterization of an exo-α-sialidase in bifidobacteria. |
T5 |
650-747 |
Sentence |
denotes |
Here we describe the identification and characterization of an exo-α-sialidase in bifidobacteria. |
T5 |
650-747 |
Sentence |
denotes |
Here we describe the identification and characterization of an exo-α-sialidase in bifidobacteria. |
TextSentencer_T6 |
748-959 |
Sentence |
denotes |
By expression cloning, we isolated a novel exo-α-sialidase gene (siabb2) from B. bifidum JCM1254, which encodes a protein (SiaBb2) consisting of 835-amino-acid residues with a predicted molecular mass of 87 kDa. |
T6 |
748-959 |
Sentence |
denotes |
By expression cloning, we isolated a novel exo-α-sialidase gene (siabb2) from B. bifidum JCM1254, which encodes a protein (SiaBb2) consisting of 835-amino-acid residues with a predicted molecular mass of 87 kDa. |
T6 |
748-959 |
Sentence |
denotes |
By expression cloning, we isolated a novel exo-α-sialidase gene (siabb2) from B. bifidum JCM1254, which encodes a protein (SiaBb2) consisting of 835-amino-acid residues with a predicted molecular mass of 87 kDa. |
TextSentencer_T7 |
960-1212 |
Sentence |
denotes |
SiaBb2 possesses an N-terminal signal sequence, a sialidase catalytic domain classified into the glycoside hydrolase family 33 (GH33) and a C-terminal transmembrane region, indicating that the mature SiaBb2 is an extracellular membrane-anchored enzyme. |
T7 |
960-1212 |
Sentence |
denotes |
SiaBb2 possesses an N-terminal signal sequence, a sialidase catalytic domain classified into the glycoside hydrolase family 33 (GH33) and a C-terminal transmembrane region, indicating that the mature SiaBb2 is an extracellular membrane-anchored enzyme. |
T7 |
960-1212 |
Sentence |
denotes |
SiaBb2 possesses an N-terminal signal sequence, a sialidase catalytic domain classified into the glycoside hydrolase family 33 (GH33) and a C-terminal transmembrane region, indicating that the mature SiaBb2 is an extracellular membrane-anchored enzyme. |
TextSentencer_T8 |
1213-1346 |
Sentence |
denotes |
The recombinant enzyme expressed in Escherichia coli showed the highest activity in an acidic pH range from 4.0 to 5.0, and at 50 °C. |
T8 |
1213-1346 |
Sentence |
denotes |
The recombinant enzyme expressed in Escherichia coli showed the highest activity in an acidic pH range from 4.0 to 5.0, and at 50 °C. |
T8 |
1213-1462 |
Sentence |
denotes |
The recombinant enzyme expressed in Escherichia coli showed the highest activity in an acidic pH range from 4.0 to 5.0, and at 50 °C. Notably, 80% activity remained after 30 min incubation at 80 °C, indicating that the enzyme is highly thermostable. |
TextSentencer_T9 |
1347-1462 |
Sentence |
denotes |
Notably, 80% activity remained after 30 min incubation at 80 °C, indicating that the enzyme is highly thermostable. |
T9 |
1347-1462 |
Sentence |
denotes |
Notably, 80% activity remained after 30 min incubation at 80 °C, indicating that the enzyme is highly thermostable. |
TextSentencer_T10 |
1463-1698 |
Sentence |
denotes |
SiaBb2 liberated sialic acids from sialyloligosaccharides, gangliosides, glycoproteins and colominic acid; however, the linkage preference of the enzyme was remarkably biased toward the α2,3-linkage rather than α2,6- and α2,8-linkages. |
T9 |
1463-1698 |
Sentence |
denotes |
SiaBb2 liberated sialic acids from sialyloligosaccharides, gangliosides, glycoproteins and colominic acid; however, the linkage preference of the enzyme was remarkably biased toward the α2,3-linkage rather than α2,6- and α2,8-linkages. |
T10 |
1463-1698 |
Sentence |
denotes |
SiaBb2 liberated sialic acids from sialyloligosaccharides, gangliosides, glycoproteins and colominic acid; however, the linkage preference of the enzyme was remarkably biased toward the α2,3-linkage rather than α2,6- and α2,8-linkages. |
TextSentencer_T11 |
1699-1857 |
Sentence |
denotes |
Expression of siabb2 in B. longum 105-A, which has no endogenous exo-α-sialidase, enabled this strain to degrade sialyloligosaccharides present in human milk. |
T10 |
1699-1857 |
Sentence |
denotes |
Expression of siabb2 in B. longum 105-A, which has no endogenous exo-α-sialidase, enabled this strain to degrade sialyloligosaccharides present in human milk. |
T11 |
1699-1857 |
Sentence |
denotes |
Expression of siabb2 in B. longum 105-A, which has no endogenous exo-α-sialidase, enabled this strain to degrade sialyloligosaccharides present in human milk. |
TextSentencer_T12 |
1858-1960 |
Sentence |
denotes |
Our results suggest that SiaBb2 plays a crucial role in bifidobacterial catabolism of sialylated HMOs. |
T11 |
1858-1960 |
Sentence |
denotes |
Our results suggest that SiaBb2 plays a crucial role in bifidobacterial catabolism of sialylated HMOs. |
T12 |
1858-1960 |
Sentence |
denotes |
Our results suggest that SiaBb2 plays a crucial role in bifidobacterial catabolism of sialylated HMOs. |